Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: Mid-season analysis 2012/13

J. McMenamin*, N. Andrews, C. Robertson, D. M. Fleming, H. Durnall, B. von Wissmann, J. Ellis, A. Lackenby, S. Cottrell, B. Smyth, M. Zambon, C. Moore, J. M. Watson, R. G. Pebody

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)

Abstract

The early experience of the United Kingdom (UK) is that influenza B has dominated the influenza 2012/13 season. Overall trivalent influenza vaccine (TIV) adjusted vaccine effectiveness (VE) against all laboratory-confirmed influenza in primary care was 51% (95% confidence interval (CI): 27% to 68%); TIV adjusted VE against influenza A alone or influenza B alone was 49% (95% CI: -2% to 75%) and 52% (95% CI: 23% to 70%) respectively. Vaccination remains the best protection against influenza.

Original languageEnglish
JournalEurosurveillance
Volume18
Issue number5
DOIs
Publication statusPublished - Jan 2013

Fingerprint

Dive into the research topics of 'Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: Mid-season analysis 2012/13'. Together they form a unique fingerprint.

Cite this